Registration
REGISTER FOR THE CONFERENCE
Apply to Exhibit
APPLICATION FOR EXHIBITION
Sponsorship
SPONSORSHIP APPLICATION
Hung Hsiu-chu, Former Chairman of the Chinese Kuomintang, Visits CGN Yangjiang Nuclear Power Base
From August 15 to 19, the Second Cross-Strait Folk Customs and Sports Festival - Nanhai (Yangjiang) Fishing Season Opening Folk Culture Exchange Activity was held in Yangjiang. Prior to the event, Hung Hsiu-chu, former Chairman of the Chinese Kuomintang and Chairwoman of the China Youth Eagle Peace Education Foundation, led a delegation to visit the CGN Yangjiang Nuclear Power Base on August 15 for an on-site inspection of the nuclear power industry's development achievements. Yang Jianbing, Secretary of the Party Committee and Chairman of Yangjiang Nuclear Power, accompanied the delegation throughout the visit and provided explanations. Zhao Yu, Second-Level Inspector of the Liaison Bureau of the Taiwan Work Office of the CPC Central Committee and the Taiwan Affairs Office of the State Council, Pan Jianyong, Deputy Director of the Taiwan Affairs Office of the Guangdong Provincial Party Committee, Lu Yixian, Secretary of the Yangjiang Municipal Party Committee and Director of the Standing Committee of the Municipal People's Congress, and Li Kun, Secretary of the Yangdong District Party Committee, accompanied the visit. During the visit, Hung Hsiu-chu and her delegation...
2026-08-21
Uzbekistan Prepares for Second Nuclear Power Plant Project
2026-08-21
Indonesia Holds Meeting with Russia on Regulatory Framework for Floating Nuclear Power Plants
2026-08-21
U.S. University Develops Laser De-icing Technology for Nuclear Power Plant Safety System Maintenance
2026-08-21
U.S. SYNOPTICS Produces Large-Size Yb:YLF Crystal for Inertial Confinement Fusion Laser Systems
2026-08-21
South Korea Amends Nuclear Safety Act to Clarify Safety Responsibilities of Nuclear Facility Operators
2026-08-21
Organizational Diagnostic Assessment Completed at Russia's Smolensk Nuclear Power Plant
2026-08-21
US Inertia Fusion Fuel Preparation Time Significantly Reduced
2026-08-21
Two US Companies Partner to Bring AI to Nuclear Power Plant Simulation Training
2026-08-21
In recent years, Shaanxi Province has continuously strengthened the construction of its radiation environmental monitoring network. The 22 atmospheric radiation automatic monitoring stations across the province, including 12 national-controlled stations and 10 provincial-controlled stations, have maintained stable operation. These stations utilize high-pressure ionization chambers, ultra-high-flow aerosol samplers, gamma spectrometers, and other equipment to conduct continuous monitoring of atmospheric instantaneous gamma dose rates, aerosol samples, and gamma radionuclides. Relevant data are transmitted in real time to the system platform of the Shaanxi Provincial Nuclear and Radiation Safety Supervision Station. According to reports, Shaanxi has gradually established an automatic station operation and maintenance management system featuring strong organization, closed-loop responsibility, funding guarantees, standardized procedures, and digital-intelligent empowerment. In 2023, the 5-minute data acquisition rate of Shaanxi's 12 national-controlled stations reached 99.9%, ranking third nationwide.
2026-08-21
Recently, under the coordinated deployment and on-site supervision of the Huangshi Municipal Ecological Environment Bureau in Hubei Province, a retired Category IV Cobalt-60 (Co-60) radioactive source was transported in a closed loop by a professionally qualified vehicle and safely delivered to the Hubei Provincial Urban Radioactive Waste Repository, where it was permanently sealed in a standardized manner. The collection and storage process for this waste source followed standard procedures with meticulous control, and no readings exceeding limits, equipment loosening, or other safety anomalies occurred throughout the entire transport process. It is understood that this Cobalt-60 radioactive source was originally the core component of a level gauge supporting an enterprise's kiln production line. As the production line was dismantled and scrapped, the related equipment ceased operation, increasing the safety management pressure of the idle radioactive source. Upon receiving the enterprise's disposal application, the Huangshi Municipal Ecological Environment Bureau...
2026-08-21
China-based Norroy Bioscience announced on August 19 that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy and Fast Track designations to its radiopharmaceutical imaging agent 68Ga-NYM096. The agent is a PET imaging tracer targeting carbonic anhydrase IX (CAIX), intended for imaging clear cell renal cell carcinoma (ccRCC). According to the company, 68Ga-NYM096 is being developed as a non-invasive PET imaging tool to characterize renal masses detected by CT or MRI and to help distinguish clear cell renal cell carcinoma from other non-ccRCC renal lesions. Clear cell renal cell carcinoma is the most common subtype of renal cell carcinoma...
2026-08-21
The International Atomic Energy Agency (IAEA) recently launched a four-year coordinated research project aimed at optimizing the experimental design of nuclear fuel and structural materials testing in research reactors, enhancing the safety, effectiveness, and efficiency of irradiation experiments. Top view showing a materials testing reactor core loaded with two in-core materials testing devices. (Photo: Y. Ostrovsky/MIT) With the continued advancement of new nuclear reactor technologies, growing interest in small modular reactors, and existing nuclear power plants seeking long-term operation, the demand for reliable testing of new nuclear fuels and structural materials is increasing. Before being put into use in nuclear reactors, these fuels and materials must be tested and qualified under harsh conditions such as radiation and high temperatures...
2026-08-21
On August 17, Luo Xu, General Manager of Atom High-Tech, and Liu Wen, Chairman of CNNC Headway, led a delegation to Tsinghua University for a business cooperation exchange with the School of Biomedical Engineering. Hu Ye, Dean of the School of Biomedical Engineering, and Ma Kai, Associate Professor of the School, attended the exchange. The visit aimed to leverage the research and talent advantages of a top-tier university, promote deep integration of industry, academia, and research, and jointly explore new cooperation opportunities in the fields of nuclear medicine and biomedical engineering. During the exchange meeting, Atom High-Tech and CNNC Headway respectively introduced their corporate development histories, core business layouts, and future strategic plans. Subsequently, Dean Hu Ye and Associate Professor Ma Kai respectively introduced...
2026-08-21
Following the institutional partnership established between CEPID CancerThera and the Uruguayan Center for Molecular Imaging (CUDIM) in February this year, a Brazilian delegation visited Montevideo, Uruguay, from July 27 to 29 to advance the transformation of the memorandum of understanding into a concrete work plan. The visit focused on multicenter clinical trials, preclinical research, theranostics in oncology, and educational cooperation. During the visit, Brazilian researchers held working meetings with the CUDIM team, covering multiple aspects of oncology research development. CUDIM was represented by its General Director Alarico Rodriguez, as well as radiopharmacist and Technical Director of Radiopharmacy, Dr. Eduardo Osvaldo Savio Queve...
2026-08-20
Akiram Therapeutics, a Swedish clinical-stage biotechnology company, and ITM Isotope Technologies Munich SE, a German radiopharmaceutical biotechnology company, recently announced the signing of a supply agreement. Under the agreement, ITM will supply no-carrier-added lutetium-177 (nca Lu-177) to Akiram to support the clinical development of its targeted antibody-radionuclide conjugate, 177Lu-AKIR001 (AKIR001). AKIR001 is Akiram's lead radiopharmaceutical candidate, currently being investigated in clinical studies for the treatment of CD44v6-expressing solid tumors. The candidate combines the therapeutic radioisotope nca Lu-177 with a proprietary antibody targeting CD44v6. CD...
2026-08-20
